KR880002503A - 국소 적용을 위한 다-격실 팩 - Google Patents
국소 적용을 위한 다-격실 팩 Download PDFInfo
- Publication number
- KR880002503A KR880002503A KR870009174A KR870009174A KR880002503A KR 880002503 A KR880002503 A KR 880002503A KR 870009174 A KR870009174 A KR 870009174A KR 870009174 A KR870009174 A KR 870009174A KR 880002503 A KR880002503 A KR 880002503A
- Authority
- KR
- South Korea
- Prior art keywords
- pack
- compartment
- gel
- compartments
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 성분들중 적어도 성분(B)가 성분(A)와 분리 되도록 유지되며 팩의 각 결실들이 파열성 칸막이에 의해 인접 격실이나 격실들로 부터 분리되는 팩속의 적어도 두개이상의 분리 격실안에 하기 성분(a), (b)와 (c)를 함유하며, 투약 직전 전에 치료물질을 함유하는 겔을 형성하도록 각 칸막이를 파열시켜 모든 성분을 함께 섞을 수 있는, 겔로서 단위 적량 형태의 치료 물질을 국소 적용하기 위한 다-격실 팩 : (A)(i)약제학적으로 허용되는 겔-형성 중 합체의 용액, 또는 (ii) 혼합시 그러한 용액을 형성하는 분리 중합체와 용매 성분 ; (B) 상기 겔-형성 중합체의 용액을 겔화시키기 위한 시약 ; 및 (C) 단위 적량의 치료 물질.
- 제1항에 있어서, 성분(A) 및/또는 성분(B)의 존재시에 불안정하여 그 혼합물의 저장시 치료활성이 악화되는 치료 물질(C)를 성분(C)와 함께 존재시 불안정한 다른 성분들과 분리시켜 팩에 포함시키는 팩.
- 제1항 또는 제2항에 있어서, 팩의 각 격실의 내부벽과 각 격실내 포함된 성분들이 멸균상태인 포장.
- 제1항 내지 제3항중 어느 하나에 있어서, 팩이 적절한 탄성 필름 물질로 부터 만들어지는데, 그 주변 가장 자리가 밀봉되어 밀폐된 탄성포장을 형성하며, 그 포장의 반대면들은 면들 사이로까지 확장된 하나이상의 파열성 칸막이나 칸막이들을 형성하는 봉합선을 따라 함께 밀봉되어 격실을 형성하는 팩.
- 제1항 내지 제4항중 어느 하나에 있어서, 다-격실 팩인 팩.
- 제5항에 있어서, 한 격실에는 약제학적으로 허용되는 겔-형성 중합체의 용액이 함유되며 다른 격실에는 요구되는 적용량의 치료물질과 중합체의 겔화를 위한 시약이 함유되어 있는 팩.
- 제1항 내지 제6항중 어느 하나에 있어서, 약제학적으로 허용되는 겔 형성 중합체의 용액이 고분자량의 카르복시비닐 중합체의 수성용액이며 중합체의 겔화를 위한 시약이 염기인 팩.
- 제1항 내지 제7항중 어느 하나에 있어서, 치료물질이 스트렙토키나제와 스트렙토도르나제의 혼합물로 이루어지는 팩.
- 팩이 암력-파열성 봉함에 의해 두 격실로 내부가 분리된 내부 멸균 유연 팩이며, 첫번째 격실에는 1,000,000이상의 분자량을 갖는 멸균 수성 용액이 함유되며, 두번째 격실에는 멸균 형태로 10,000-200,000단위의 스트렙 토키나제, 2,500-약 50,000단위의 스트렙토도르나제와 두 격실의 내용물이 섞여지도록 팩을 외부에서 손조작함으로써 봉합 분리 두 격실이 파열될 때 수성 중합체 용액을 겔화시키기에 충분한 양의 무기혹은 유기 염기가 함유된, 겔로서 단위 적용량 형태의 스트렙토키나제와 스트렙토도르나제의 혼합물의 적용하기 위한 팩.
- 제9항에 있어서, 두번째 격실에 스트렙토키나제와 스트렙토도르나제의 멸균 부형제가 더 함유된 팩.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8620425A GB2194144B (en) | 1986-08-22 | 1986-08-22 | Stable pharmaceutical gel preparation |
GB8620425 | 1986-08-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880002503A true KR880002503A (ko) | 1988-05-09 |
Family
ID=10603089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR870009174A KR880002503A (ko) | 1896-08-22 | 1987-08-21 | 국소 적용을 위한 다-격실 팩 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0264552A3 (ko) |
JP (1) | JPS6389160A (ko) |
KR (1) | KR880002503A (ko) |
AU (1) | AU599410B2 (ko) |
DK (1) | DK436987A (ko) |
FI (1) | FI873630A (ko) |
GB (1) | GB2194144B (ko) |
NO (1) | NO873534L (ko) |
PH (1) | PH26303A (ko) |
PT (1) | PT85544A (ko) |
ZA (1) | ZA876222B (ko) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA902066B (en) * | 1989-04-14 | 1990-12-28 | Minnesota Mining & Mfg | Solid gel external drug delivery system |
US5804213A (en) | 1991-10-09 | 1998-09-08 | Lectec Corporation | Biologically active aqueous gel wound dressing |
US6620436B1 (en) | 1991-10-09 | 2003-09-16 | Lectec Corporation | Mixing and dispensing package for a wound dressing |
JPH07500035A (ja) * | 1991-10-09 | 1995-01-05 | レクテック コーポレイション | 水性ゲル傷用包帯剤およびパッケージ |
DE4223004A1 (de) * | 1992-07-13 | 1994-01-20 | Liedtke Pharmed Gmbh | Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie |
DE4435805A1 (de) * | 1994-10-06 | 1996-04-11 | Knoll Ag | Zweikomponenten-Creme |
DE19602208A1 (de) * | 1996-01-23 | 1997-07-24 | Nordmark Arzneimittel Gmbh | In-situ gebildete Arzneiform zur Abgabe von Enzymen an Wunden |
US5977428A (en) * | 1996-12-20 | 1999-11-02 | Procyte Corporation | Absorbent hydrogel particles and use thereof in wound dressings |
GB2328443B (en) | 1997-08-21 | 2001-09-05 | Reckitt & Colmann Prod Ltd | In situ formation of pharmaceutically acceptable polymeric material |
US6702744B2 (en) | 2001-06-20 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery |
US8608661B1 (en) | 2001-11-30 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Method for intravascular delivery of a treatment agent beyond a blood vessel wall |
US7361368B2 (en) | 2002-06-28 | 2008-04-22 | Advanced Cardiovascular Systems, Inc. | Device and method for combining a treatment agent and a gel |
US8038991B1 (en) | 2003-04-15 | 2011-10-18 | Abbott Cardiovascular Systems Inc. | High-viscosity hyaluronic acid compositions to treat myocardial conditions |
US8821473B2 (en) | 2003-04-15 | 2014-09-02 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US7641643B2 (en) | 2003-04-15 | 2010-01-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US7854944B2 (en) | 2004-12-17 | 2010-12-21 | Advanced Cardiovascular Systems, Inc. | Tissue regeneration |
US8828433B2 (en) | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US8303972B2 (en) | 2005-04-19 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
US8187621B2 (en) | 2005-04-19 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Methods and compositions for treating post-myocardial infarction damage |
US20080125745A1 (en) | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
US20090023638A1 (en) * | 2006-02-06 | 2009-01-22 | Taro Pharmaceuticals North American, Inc. | Spill resistant antibiotic formulations |
US7732190B2 (en) | 2006-07-31 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
CN1944378A (zh) * | 2006-10-23 | 2007-04-11 | 广东中科药物研究有限公司 | 一种联苯乙酸氨丁三醇盐及其制备方法 |
US9005672B2 (en) | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
US8741326B2 (en) | 2006-11-17 | 2014-06-03 | Abbott Cardiovascular Systems Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US8192760B2 (en) | 2006-12-04 | 2012-06-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating tissue using silk proteins |
FR3034016A1 (fr) * | 2015-03-27 | 2016-09-30 | Inst Nord Sud De Coop Biopharmaceutique | Sachet pour la preparation d'une formulation pharmaceutique destinee a une administration orale, disposition comprenant un tel sachet et procedes de preparation associes |
CN113197791B (zh) * | 2021-04-26 | 2023-03-28 | 中山市粤美医疗生物科技有限公司 | 一种水润喷雾面膜及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB799069A (en) * | 1956-04-24 | 1958-07-30 | American Cyanamid Co | Compositions for the reversal of inflamation in animals |
US3608709A (en) * | 1969-09-08 | 1971-09-28 | Wayne Rogers V | Multiple compartment package |
US4276281A (en) * | 1980-09-04 | 1981-06-30 | Crikelair George F | Burn treatment |
-
1986
- 1986-08-22 GB GB8620425A patent/GB2194144B/en not_active Expired - Fee Related
-
1987
- 1987-08-04 EP EP87111214A patent/EP0264552A3/en not_active Ceased
- 1987-08-17 PT PT85544A patent/PT85544A/pt not_active Application Discontinuation
- 1987-08-21 AU AU77299/87A patent/AU599410B2/en not_active Ceased
- 1987-08-21 KR KR870009174A patent/KR880002503A/ko not_active Application Discontinuation
- 1987-08-21 NO NO873534A patent/NO873534L/no unknown
- 1987-08-21 FI FI873630A patent/FI873630A/fi not_active Application Discontinuation
- 1987-08-21 PH PH35716A patent/PH26303A/en unknown
- 1987-08-21 ZA ZA876222A patent/ZA876222B/xx unknown
- 1987-08-21 DK DK436987A patent/DK436987A/da not_active Application Discontinuation
- 1987-08-21 JP JP62206607A patent/JPS6389160A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA876222B (en) | 1988-02-23 |
GB2194144A (en) | 1988-03-02 |
JPS6389160A (ja) | 1988-04-20 |
NO873534L (no) | 1988-02-23 |
DK436987D0 (da) | 1987-08-21 |
GB8620425D0 (en) | 1986-10-01 |
PH26303A (en) | 1992-04-29 |
FI873630A0 (fi) | 1987-08-21 |
FI873630A (fi) | 1988-02-23 |
EP0264552A2 (en) | 1988-04-27 |
NO873534D0 (no) | 1987-08-21 |
GB2194144B (en) | 1990-04-25 |
PT85544A (pt) | 1988-08-17 |
EP0264552A3 (en) | 1989-01-18 |
DK436987A (da) | 1988-02-23 |
AU7729987A (en) | 1988-02-25 |
AU599410B2 (en) | 1990-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880002503A (ko) | 국소 적용을 위한 다-격실 팩 | |
US4610684A (en) | Flexible container and mixing system for storing and preparing I.V. fluids | |
DK0541715T3 (da) | Fleksibel flerkammer-medikamentbeholder | |
JP2890142B2 (ja) | 重炭酸塩を含有する粉末製剤収容容器及び該製剤の安定化法 | |
US10065784B2 (en) | Packaged medicine-filled container | |
ATE491427T1 (de) | Flexibler medizinischer mehrkammerbehälter mit vorzugsweise aufreissbaren nähten | |
BR9814960A (pt) | Recipiente médico flexìvel com compartimentos que podem ser seletivamente aumentados e um método para confecção do mesmo | |
BR9713627A (pt) | Recipiente para medicamento para estocagem de um medicamento lìquido, e, uso do mesmo | |
PT82687B (pt) | Acondicionamento estanque sob a forma de placa alveolar que permite permutas gasosas entre os alveolos | |
BR9708993A (pt) | Recipiente flexìvel para droga, com compartimentos múltiplos, e método de fabricação e uso do mesmo | |
CO4340640A1 (es) | Recipiente esteril, flexible y metodo para fabricarlo y usarlo | |
ID20475A (id) | Wadah dan metoda untuk penyimpanan dan pencampuran larutan obat | |
WO2008121298A1 (en) | Multi-compartment package | |
BR0105971A (pt) | Embalagem para multicomponentes | |
KR890010069A (ko) | 열가소성폴리머에 대전특성을 제공하는 대전방지제와 그 대전방지제를 포함한 열가소성폴리머조성물 | |
JP5474287B2 (ja) | 薬剤充填済医療用容器および薬剤充填済医療用容器包装体 | |
GB1316323A (en) | Mixing vial | |
PE20211892A1 (es) | Composicion liquida de clotrimazol envasada de dosis unica | |
BR112021013269B1 (pt) | Embalagens blister que contêm material ativo e métodos para produzir e usar as mesmas | |
KR890012673A (ko) | 혈소판보존용백 및 그것을 사용한 복합백 | |
BRPI0415082A (pt) | método para a utilização de um material e recipiente de embalagem para a execução do método | |
BR112019003984B1 (pt) | Embalagem de blister | |
RU2360853C2 (ru) | Контейнер для хранения фармацевтических рецептур | |
RU2134565C1 (ru) | Способ подготовки парантерального лекарственного средства к хранению | |
TH50350B (th) | กระเป๋าที่มีหลายช่องและแผ่นฟิล์มปิดกั้นก๊าซ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITB | Written withdrawal of application |